Acute heart failure syndromes in the pediatric emergency department

Pediatrics

Volumn 124, Issue 5, 2009, Pages

  Macicek, Scott M ^a   Macias, Charles G ^a   Jefferies, John L ^a   Kim, Jeffrey J ^a   Price, Jack F ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Emergency medicine; Heart failure; Pediatrics

Indexed keywords

ADRENALIN; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; INOTROPIC AGENT; LOOP DIURETIC AGENT; MILRINONE; NESIRITIDE; THIAZIDE DIURETIC AGENT; VASOACTIVE AGENT; WARFARIN;

ABDOMINAL PAIN; ACUTE HEART FAILURE; ARTICLE; ASSISTED CIRCULATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; COUGHING; CROSS-SECTIONAL STUDY; DIAPHORESIS; DIARRHEA; ECHOCARDIOGRAPHY; EMERGENCY WARD; FATIGUE; FEMALE; HEART VENTRICLE FUNCTION; HEPATOMEGALY; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; JUGULAR VEIN; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; MORTALITY; NAUSEA; OXYGEN SATURATION; PEDIATRIC WARD; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SYMPTOM; TACHYCARDIA; TACHYPNEA; THORAX PAIN; THORAX RADIOGRAPHY; VOMITING; WHEEZING;

ACUTE DISEASE; BLOOD CHEMICAL ANALYSIS; CARDIOTONIC AGENTS; CHILD; COLLOIDS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; ISOTONIC SOLUTIONS; MALE; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 70350508326     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2198     Document Type: Article

References (21)

1. Koelling TM, Chen RS, Lubwama RN, L'Italien GJ, Eagle KA. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J. 2004;147(1):74-78
2. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary-a report of the American College of Cardiology/American heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38(7):2101-2113
3. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2): 209-216
4. Zannad F, Briancon S, Juilliere Y, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. J Am Coll Cardiol. 1999;33(3): 734-742
5. Fonarow GC, Adams KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure (classification and regression tree analysis). JAMA. 2005;293(5):572-580 (Pubitemid 40171239)
6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167 (Pubitemid 34764819)
7. Mueller C, Laule-Killian K, Scholer A, et al. Use of B-type natriuretic peptide for the management of women with dyspnea. Am J Cardiol. 2004;94(12):1510-1514 (Pubitemid 40268452)
8. Levitt MA. A prospective, randomized trial of BiPAP in severe acute congestive heart failure. J Emerg Med. 2001;21(4):363-369
9. Masip J, Betbese AJ, Paez J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet. 2000;356(9248):2126-2132 (Pubitemid 32047948)
10. Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998; 351(9100):389-393 (Pubitemid 28064161)
11. Silvers SM, Howell JM, Kosowsky JM, Rokos IC, Jagoda AS, American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Acute Heart Failure Syndromes. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann Emerg Med. 2007;49(5):627-669
12. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol. 2004;25(4): 341-346 (Pubitemid 38989517)
13. Gheorghiade F, Zannad G, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112(25):3958-3968 (Pubitemid 43739494)
14. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 suppl 4th report):555-576
15. Iliff A, Lee VA. Pulse rate, respiratory rate, and body temperature of children between two months and eighteen years of age. Child Dev. 1952;23(4):237-245
16. Barnes LA. Pediatric history and physical examination. In: McMillan JA, Feigen RD, DeAngelis CD, Jones MD, eds. Oski's Pediatrics Principles and Practice. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:39-52
17. Acute Decompensated Heart Failure Registry (ADHERE) Final Cumulative Benchmark Report, Quarter 1. Available at: www.adhereregistry.com. Accessed December 1, 2006
18. Peacock WF, Holland R, Gyarmathy R, et al. Observation unit treatment of heart failure with nesiritide: results from the PROACTION Trial. J Emerg Med. 2005;29(3):243-252 (Pubitemid 41383844)
19. Peacock WF,EmermanCL, Silver MA. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Am J Emerg Med. 2005; 23(3):327-331
20. Peacock WF, Fonarow GC, Emerman CL, Mills RM, Wynne J, ADHERE Scientific Advisory Committee and Investigators and the ADHERE Study Group. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology. 2007;107(1):44-51
21. Price JF, Thomas AK, Grenier M, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006;114(10):1063-1069 (Pubitemid 44358883)